UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 10, 2019 9:30 A.M.
Form:
S-3
CIK:
0001621227
Company Name:
Adaptimmune Therapeutics PLC
File Number:
333-233557